Covance Doubles Singapore CRO Lab Size To Meet Asia-Pacific Demands
This article was originally published in PharmAsia News
Covance said it has completed a doubling of the size of its central laboratory in Singapore, the nation's largest, to meet growth demands in the Asia Pacific region, particularly China and Japan.
You may also be interested in...
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.
The German biotech has developed its COVID-19 vaccine in record-breaking time, but artificial intelligence could help accelerate drug discovery over the longer term.
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.